Alembic Pharmaceuticals has received USFDA approval for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis. The approved product is therapeutically equivalent to the reference […]
Zydus Cadila has received final USFDA approval to market generic Lansoprazole delayed release orally disintegrating tablets in the strengths of 15 mg and 30 mg. […]
Glenmark Pharmaceuticals has received final USFDA approval for Fluocinolone Acetonide Oil which is used to treat eczema of the ear. The drug is a generic […]
Lupin has received USFDA approval to market Clobazam tablets in the US market. The drug Clobazam tablets in strengths of 10 mg and 20 mg […]
Glenmark Pharmaceuticals has received final USFDA approval market Hydrocortisone Valerate ointment in US markets. The ointment is used to treat a variety of skin conditions […]
Strides Pharma Science through its venture partner Strides Vivimed Pte Ltd, Singapore has received USFDA approval for Albendazole tablets in the strength of 200 mg. […]
Dr Reddy’s Laboratories Ltd has received USFDA approval for Aspirin and extended-release Dipyridamole capsules. The drug is a therapeutic equivalent generic version of Aggrenox (Aspirin […]
Lupin has received USFDA approval for Atovaquone Oral Suspension USP, 750 mg/5 million. The drug is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, […]
Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Albendazole Tablets in strength of 200mg. The drug Albendazole Tablets 200mg […]
Zydus Cadila has received final USFDA approval to market Exemestane tablets, used for treatment of breast cancer. The drug in the strength of 25 mg […]
Copyright © 2024 | WordPress Theme by MH Themes